Craft

Argent BioPharma

Stock Price

$0.3

2024-06-03

Market Capitalization

$18.4 M

2024-06-03

Revenue

$181 K

FY, 2025

Argent BioPharma Summary

Company Summary

Overview
Argent BioPharma (formerly MGC Pharmaceuticals) is a biopharma company focusing on the cannabinoid (CBD) and medical cannabis business. It supplies GMP (good manufacturing practice) phytocannabinoid derived medicines to patients.
Type
Public
Status
Active
Founded
2015
HQ
London, GB | view all locations
Website
https://argentbiopharma.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

LocationsView all

4 locations detected

  • London, England HQ

    United Kingdom

    Eccleston Yards, 25 Eccleston Pl, Belgravia

  • West Perth, WA

    Australia

    1202 Hay St

  • Hlavní město Praha

    Czech Republic

    6, Ve Smečkách 1258/6

  • Ljubljana, Ljubljana

    Slovenia

    Emonska cesta 8

Argent BioPharma Financials

Summary Financials

Revenue (H1, 2026)
$171.0K
Gross profit (H1, 2026)
$98.0K
Net income (H1, 2026)
($2.9M)
Cash (H1, 2026)
$1.5M
EBIT (H1, 2026)
($2.8M)

Footer menu